Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $16.56-$28.15 |
Market Cap | $1.4B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $384M |
Revenue Growth (YoY) | 67.4% |
Gross Profit (12 Mos) | $173.2M |
Diluted EPS | -$0.12 |
News
See moreYahoo Finance • 4 months ago
Roth analysis: Has volatility created a trigger warning for stocks?
Yahoo Finance • 11 months ago
Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year
Yahoo Finance • last year
Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
Yahoo Finance • last year
12 Cheap Biotech Stocks Smart Investors Are Piling Into
About
CEO | Mr. Sanj K. Patel |
CFO | Mr. Mark Ragosa C.F.A. |
Address | 23 Old Bond Street, London, United Kingdom, WIS 4PZ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 297 |
